Crystal engineering of lactose using electrospray technology: carrier for pulmonary drug delivery

References

• Marianecci C, Di Marzio L, Rinaldi F, et al. Pulmonary delivery: innovative approaches and perspectives. J Biomater Nanobiotechnol. 2011;2:567–575.
   Google Scholar
• Carpenter J, Pikal M, Chang B, et al. Rational design of stable lyophilized protein formulations: some practical advice. Pharm Res. 1997;14:969?975.
   PubMed Web of Science ®Google Scholar
• Prime D, Atkins P, Slater A, et al. Review of dry powder inhalers. Adv Drug Deliv Rev. 1997;26:51–58.
   PubMed Web of Science ®Google Scholar
• Iida K, Hayakawa Y, Okamoto H, et al. Effect of surface covering of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate. Chem Pharm Bull. 2003;51:1455–1457.
   PubMed Web of Science ®Google Scholar
• Schiavone H, Palakodaty S, Clark A, et al. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers. Int J Pharm. 2004;281:55.
   PubMed Web of Science ®Google Scholar
• Zeng X, Martin G, Tee S, et al. Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation. Int J Pharm. 1999;182:133–144.
   PubMed Web of Science ®Google Scholar
• Zeng X, Martin G, Marriott C, et al. The Influence of crystallization conditions on the morphology of lactose intended for use as a carrier for dry powder aerosols. J Pharm Pharmacol. 2000;52:633–643.
   PubMed Web of Science ®Google Scholar
• Labiris N, Dolovich M. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003;56:600–612.
   PubMed Web of Science ®Google Scholar
• Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm. 2010;392:1–19.
   PubMed Web of Science ®Google Scholar
• Rowe R, Sheskey P, Owen S, Lactose. In: Handbook of pharmaceutical excipients. 5th ed. London (UK): London Pharmaceutical Press; 2000, p. 385–395.
   Google Scholar
• Liang B, Shi Y, Hartel R. Growth rate dispersion effects on lactose crystal size distributions from a continuous cooling crystallizer. J Food Sci. 1991;56:848–854.
   Web of Science ®Google Scholar
• Bund R, Pandit A. Rapid lactose recovery from buffalo whey by use of anti solvent, ethanol. J Food Eng. 2007;82:333–341.
   Web of Science ®Google Scholar
• Larhrib H, Martin G, Prime D, et al. Characterization and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolized salbutamol sulphate from dry powder inhalers. Eur J Pharm Sci. 2003;19:211–221.
   PubMed Web of Science ®Google Scholar
• Leviton A. Methanol extraction of lactose and soluble proteins from skim milk powder. Ind Eng Chem. 1949;41:1351–1357.
   Web of Science ®Google Scholar
• Dincer T, Parkinson G, Rohl A, et al. Crystallization of α-lactose monohydrate from dimethyl sulphoxide (DMSO) solution: influnce of β-lactose. J Cryst Growth. 1999;205:368–374.
   Web of Science ®Google Scholar
• Dhumal R, Biradar S, Paradkar A, et al. Ultrasound assisted engineering of lactose crystals. Pharm Res. 2008;25:2835–2844.
   PubMed Web of Science ®Google Scholar
• Bund R, Pandit A. Sonocrystallization: effect on lactose recovery and crystal habit. Ultrason Sonochem. 2007;14:143–152.
   PubMed Web of Science ®Google Scholar
• Zeng X, Martin G, Marriot C, et al. Crystallization of lactose from carbopol gels. Pharm Res. 2001;17:879–886.
   Web of Science ®Google Scholar
• Patil S, Mahadik K, Paradkar A. Liquid crystalline phase as a probe for crystal engineering of lactose: carrier for pulmonary drug delivery. Eur J Pharm Sci. 2015;68:43–60.
   PubMed Web of Science ®Google Scholar
• Radacsi N, Ambrus R, Szunyogh T, et al. Electrospray crystallization for nanosized pharmaceuticals with improved properties. Cryst Growth Des. 2012;12:3514–3520.
   Web of Science ®Google Scholar
• Rulison A, Flagan R. Scale-up of electrospray atomization using linear arrays of Taylor cones. Rev Sci Instrum. 1993;64:683–686.
   Web of Science ®Google Scholar
• Wang M, Rutledge G, Myerson A, et al. Production and characterization of carbamazepine nanocrystals by electrospraying for continuous pharmaceutical manufacturing. J Pharm Sci. 2012;101:1178–1188.
   PubMed Web of Science ®Google Scholar
• Kamble R, Gaikwad S, Maske A, et al. Fabrication of electrospun nanofibres of BCS II drug for enhanced dissolution and permeation across skin. J Adv Res. 2016;7:483–489.
   PubMed Web of Science ®Google Scholar
• Kaialy W, Martin G, Larhrib H, et al. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers. Colloids Surf B. 2012;89:29–39.
   PubMed Web of Science ®Google Scholar
• Ambrus R, Radacsi N, Szunyogh T, et al. Analysis of submicron-sized niflumic acid crystals prepared by electrospray crystallization. J Pharm Biomed Anal. 2013;76:1–7.
   PubMed Web of Science ®Google Scholar
• Kaialy W, Alhalaweh A, Velaga S, et al. Influence of lactose carrier particle size on the aerosol performance of budesonide from a dry powder inhaler. Powder Technol. 2012;227:74–85.
   Web of Science ®Google Scholar
• Kirk J, Dann S, Blatchford C. Lactose: a definitive guide to polymorph determination. Int J Pharm. 2007;334:103–114.
   PubMed Web of Science ®Google Scholar
• Figura L, Epple M. Anhydrous α-lactose: a study with DSC and TXRD. J Therm Anal Calorim. 1995;44:45–53.
   Web of Science ®Google Scholar
• Khankari R, Law D, Grant D. Determination of water content in pharmaceutical hydrates by differential scanning calorimetry. Int J Pharm. 1992;89:117–127.
   Web of Science ®Google Scholar
• Pilcer G, Wauthoz N, Amighi K. Lactose characteristics and the generation of the aerosol. Adv Drug Deliv Rev. 2012;64:233–256.
   PubMed Web of Science ®Google Scholar
• Ganderton D, Kassem N. Dry powder inhalers. Adv Pharm Sci. 1992;6:165–191.
   Google Scholar
• Kawashima Y, Serigano T, Hino T, et al. Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. Int J Pharm. 1998;172:179–188.
   Web of Science ®Google Scholar
• Zeng X, Martin G, Marriott C, et al. Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery. J Pharm Sci. 2001;90:1424–1434.
   PubMed Web of Science ®Google Scholar
• Bryon P, Kelly E, Kontny M. Recommendations of the USP advisory panel on aerosols on the USP general chapters on aerosols 〈601〉 and uniformity of dosage units 〈905〉. Pharm Forum. 1994;20:7477–7505.
   Google Scholar